2023年美国血液分离学会“治疗性血液分离技术临床实践指南”(第9版)解读  

Interpretation on the 2023 clinical practice guidelines of plasma component purification technology from the American Society for Apheresis(9th edition)

作　　者：万利 王梅[2] WAN Li;WANG Mei(Blood Purification Center,Department of Nephrology,Peking University International Hospital,Beijing 102206,China;Department of Nephrology,Peking University People's Hospital,Beijing 100044,China)

机构地区：[1]北京大学国际医院肾脏内科血液净化中心,北京102206 [2]北京大学人民医院肾内科,北京100044

出　　处：《中国血液净化》2024年第1期1-8,共8页Chinese Journal of Blood Purification

摘　　要：2023年4月美国血液分离学会(American Society for Apheresis,ASFA)发布了第9版《治疗性血液分离技术临床实践指南》。该指南基于目前已发表的文献,确定治疗性血液分离技术治疗疾病的证据质量及推荐强度,讨论了该技术在91种疾病(166种适应证)中的临床应用。本文重点解读血浆净化技术,即血浆置换和免疫吸附技术在临床多学科中的应用。In April 2023,the American Society for Apheresis(ASFA)released the 9th edition of guidelines for clinical practice of therapeutic apheresis.Based on published literature,these guidelines define the quality of evidence and the recommended strength of therapeutic apheresis in the treatment of diseases,and discuss the clinical application of therapeutic apheresis in 91 disease(166 indications).This article focuses on the interpretation of clinical multidisciplinary applications of plasma component purification technology,including plasma exchange and immuneadsorption.

关 键 词：血液分离技术 血浆置换 免疫吸附 临床实践指南 

分 类 号：R45[医药卫生—治疗学]